Ql. Cheng et al., PROGRESSIVE RENAL LESIONS INDUCED BY ADMINISTRATION OF MONOCLONAL-ANTIBODY-1-22-3 TO UNILATERALLY NEPHRECTOMIZED RATS, Clinical and experimental immunology, 102(1), 1995, pp. 181-185
A new animal model of progressive glomerulosclerosis was developed by
administering a single i.v, injection of MoAb 1-22-3 to unilaterally n
ephrectomized rats. Renal morphological analysis revealed that glomeru
lar lesions characterized by mesangial cell proliferation and mesangia
l matrix expansion were induced in about 95% of the glomeruli. Approxi
mately 20% of the glomeruli of the unilaterally nephrectomized rats sh
owed sclerosis or segmental sclerosis by week 6 after MoAb injection a
nd crescent formation was observed in some glomeruli (ca 4%). Cellular
infiltration was also noted in some parts of the interstitium. Increa
sed expression of transforming growth factor-beta (TGF-beta) was obser
ved in the unilaterally nephrectomized rats treated with MoAb 1-22-3,
but we could not demonstrate pathological involvement of platelet-deri
ved growth factor (PDGF), even though early-stage mesangial cell proli
feration was observed. The mechanism of mesangial cell proliferation i
n this model remains to be elucidated. The relatively short period of
time needed to induce the sclerotic changes is considered to be a grea
t advantage of this model for clarifying the mechanisms involved in th
e chronic progression of mesangial proliferative glomerulonephritis.